Applied Clinical Trials
Study shows sharp reduction in market exclusivity periods for first-in-class treatment entrants.
Tufts, CSDD
Advertisement
Articles by Tufts, CSDD
Applied Clinical Trials
Study finds that almost 75% of cancer drug candidates rely on biomarker data.
Applied Clinical Trials
Tufts CSDD
Advertisement
Latest Updated Articles
Survey Results of Start-Up Cycle TimesNovember 1st 2012
Oncology Leads Personalized MedicineJune 1st 2015
Competitive Pressure for First-in-Class Drugs is IntensifyingFebruary 1st 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
2
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
3
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
4
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
5